Literature DB >> 18680535

High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.

M Besser1, C Baglin, R Luddington, A van Hylckama Vlieg, T Baglin.   

Abstract

OBJECTIVE: To determine the predictive value of measurement of parameters of thrombin generation for unprovoked recurrent venous thrombosis.
METHODS: Measurements were made of thrombin generation in a prospective cohort study of 188 patients with a first episode of venous thrombosis that was unprovoked, or provoked by a non-surgical trigger.
RESULTS: The endogenous thrombin potential (ETP) was the only parameter associated with unprovoked recurrent thrombosis in a multivariate model [hazard ratio (HR) 1.3 per 100 nmol L min(-1) increase, 95% confidence interval (CI) 1.0-1.6]. Patients with a high ETP had a significantly higher rate of unprovoked recurrence than those with a low ETP (HR 2.9, 95% CI 1.3-6.6, cumulative recurrence at 4 years 27% vs. 11%). Patients with an unprovoked first event had a significantly higher rate of unprovoked recurrence than those with a provoking factor (HR 2.7, 95% CI 1.2-6.1), and in these patients there was a significantly higher rate of unprovoked recurrence in association with a high ETP (HR 4.0, 95% CI 1.3-11.8). After adjustment for D-dimer, thrombophilia, sex, and whether or not the first event was unprovoked, a high ETP remained a significant predictor of recurrence (HR 2.6, 95% CI 1.2-6.0).
CONCLUSIONS: This study demonstrates a high rate of unprovoked recurrent venous thrombosis in patients presenting with a first episode of venous thrombosis and a high ETP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680535     DOI: 10.1111/j.1538-7836.2008.03117.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  37 in total

1.  Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay.

Authors:  Armando Tripodi; Adriana Branchi; Veena Chantarangkul; Marigrazia Clerici; Giuliana Merati; Andrea Artoni; Pier Mannuccio Mannucci
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

2.  Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Authors:  Carolyn L Westhoff; Malcolm C Pike; Serge Cremers; Andrew Eisenberger; Stella Thomassen; Jan Rosing
Journal:  Contraception       Date:  2017-01-11       Impact factor: 3.375

Review 3.  Predicting the risk of recurrent venous thromboembolism (VTE).

Authors:  Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

4.  In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices.

Authors:  Gaurav Girdhar; Junwei Li; Larisa Kostousov; John Wainwright; Wayne L Chandler
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

5.  Thrombogenicity of the p48 and anti-thrombogenic p48 hydrophilic polymer coating low-profile flow diverters in an in vitro human thrombin generation model.

Authors:  Pervinder Bhogal; Tim Lenz-Habijan; Catrin Bannewitz; Ralf Hannes; Hermann Monstadt; Martin Brodde; Beate Kehrel; Hans Henkes
Journal:  Interv Neuroradiol       Date:  2020-05-04       Impact factor: 1.610

6.  Thrombin Generation Measurements in Patients Scheduled for Laparoscopic Bariatric Surgery.

Authors:  Jérémie Thereaux; Fanny Mingant; Charles Roche; Hubert Galinat; Francis Couturaud; Karine Lacut
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

7.  Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.

Authors:  Bryce A Kerlin; Amanda P Waller; Ruchika Sharma; Melinda A Chanley; Marvin T Nieman; William E Smoyer
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

Review 8.  New findings on venous thrombogenesis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Hamostaseologie       Date:  2016-11-23       Impact factor: 1.778

9.  Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.

Authors:  Kellie R Machlus; Emily A Colby; Jogin R Wu; Gary G Koch; Nigel S Key; Alisa S Wolberg
Journal:  Thromb Haemost       Date:  2009-11       Impact factor: 5.249

10.  Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy.

Authors:  Steffen Rosen; Stefan Tiefenbacher; Mary Robinson; Mei Huang; Jaydeep Srimani; Donnie Mackenzie; Terri Christianson; K John Pasi; Savita Rangarajan; Emily Symington; Adam Giermasz; Glenn F Pierce; Benjamin Kim; Stephen J Zoog; Christian Vettermann
Journal:  Blood       Date:  2020-11-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.